EurekaMag
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors?


Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors?



European Heart Journal 19(Suppl): L15-L21



ISSN/ISBN: 0195-668X

PMID: 9821004

The proportion of heart failure patients treated with an angiotensin-converting enzyme (ACE) inhibitor has increased over time, however, these drugs continue to be underutilized in this syndrome. There are a number of possible explanations for the failure of physicians to prescribe these agents optimally: (1) failure to recognize that heart failure is an important public health problem worthy of treatment; (2) failure to appreciate fully the magnitude of the clinical benefit of ACE inhibitors in heart failure; (3) failure to understand that the clinical benefits of ACE inhibitors fully justify the cost of these drugs; (4) concern that the adverse effects of ACE inhibitors outweigh their clinical benefits; (5) belief that the benefits observed in clinical trials do not translate into clinical practice. In reality, heart failure is a very common, extremely disabling, costly and deadly disorder. ACE inhibitors substantially reduce the morbidity and mortality related to heart failure, do this cost effectively and with a favourable risk-benefit ratio. Despite these facts, many patients are still denied ACE inhibitor therapy. An improved educational effort and clear and practical guidelines are essential if the uptake of ACE inhibitors is to increase.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031416393

Download citation: RISBibTeXText

Related references

Heart failure and angiotensin-converting enzyme inhibitors: towards evidence-based health care. British Journal of Hospital Medicine 53(5): 186-188, 1995

Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?. Journal of the American College of Cardiology 28(5): 1323-1327, 1996

Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure. Journal of Cardiovascular Pharmacology 32(6): 988-994, 1998

Controversies in heart failure. Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure?. Cardiology Clinics 19(4): 597-603, 2001

Failure to titrate angiotensin-converting enzyme inhibitors in patients hospitalized with congestive heart failure. JGIM 13(Suppl 1): 61, 1998

Angiotensin-converting enzyme inhibitors in heart failure: physicians' prescribing behavior. Journal of Cardiac Failure 3(4): 295-302, 1997

Les inhibiteurs de l'enzyme de conversion prolongent-ils la vie des patients en insuffisance cardiaque ? - Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice ?. Prise en Charge de l'Insuffisance Cardiaque. Symposium 21(5): 186-194, 1997

Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry. American Journal of Medicine 109(6): 489-492, 2000

Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure. Journal of General Internal Medicine 12(9): 523-530, 1997

The use of angiotensin-converting enzyme inhibitors in the treatment of heart failure in hospital practice. Postgraduate Medical Journal 73(861): 409-411, 1997

Clinical evidence of benefit from angiotensin converting enzyme inhibitors in heart failure. Current Opinion in Cardiology 3: S83-S96, 1988

Up-titrating angiotensin-converting enzyme inhibitors in heart failure: evidence and challenges. European Journal of Heart Failure 20(2): 370-372, 2018

Angiotensin-converting enzyme inhibitors in congestive heart failure: clinical practice guidelines. Therapie 58(4): 341-349, 2003

Survey of the use of angiotensin-converting enzyme inhibitors in the treatment of heart failure in hospital practice. European Heart Journal 17(ABSTR Suppl ): 60, 1996

Angiotensin-converting enzyme inhibitors in congestive heart failure: Practice versus guidelines. Journal of Pharmacy Technology 18(5): 229-240, 2002